← Browse by Condition
Medical Condition

analgesia

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for analgesia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — analgesia Clinical Trials

How many clinical trials are currently recruiting for analgesia?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for analgesia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for analgesia?
analgesia research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a analgesia clinical trial?
Eligibility criteria for analgesia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
University of Wisconsin, Madison 1 trial
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1 trial
Zagazig University 1 trial
Istanbul University - Cerrahpasa 1 trial
Insel Gruppe AG, University Hospital Bern 1 trial

Recruiting Clinical Trials

NCT06213454 Phase 4
Recruiting

Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery

Enrollment
80 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT06794879
Recruiting

Survey for Parental Perception of Procedural Analgosedation in Pediatric Age.

Enrollment
700 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT07235982
Recruiting

Shoulder Anterior Capsular Block and Intraarticular Steroid Injection Versus Intraarticular Steroid Injection for Enhancing Pain Relief in Adhesive Capsulitis

Enrollment
50 pts
Location
Egypt
Sponsor
Zagazig University
View Trial →
NCT06576128
Recruiting

Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions

Enrollment
100 pts
Location
Turkey (Türkiye)
Sponsor
Istanbul University - Cerrahpa...
View Trial →
NCT03489499
Recruiting

Genetic Variants and Postoperative Pain

Enrollment
5,000 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology